目的：探讨输血前对受血者四项感染性疾病指标的检测及临床意义。方法：本院2011年1月~2012年12月需要输血治疗的患者820例，分别在受血前进行梅毒螺旋体抗体(抗-TP)、人类免疫缺陷病毒抗体(抗-HIV1/2)、乙型肝炎表面抗原(HBSAg)、丙型肝炎病毒抗体(抗-HCV)四项感染性疾病指标检测，探讨受血前上述指标检测的临床意义。结果：抗-TP阳性9例，阳性率为1.10%；抗-HIV1/2阳性1例，阳性率为0.12%；HBSAg阳性65例，阳性率为7.93%；抗-HCV阳性5例，阳性率为0.61%；其中男性阳性患者56例，阳性率为13.59%；女性阳性患者24例，阳性率为5.97%；男性感染性疾病患者明显高于女性，两种性别比较差异具有显著性，有统计学意义P<0.05。结论：输血前对受血者抗-TP、抗-HIV1/2、HBSAg、抗-HCV四项感染性疾病指标的检测可以确定患者受血前是否患有以上四种与输血相关的传染性疾病，避免输血后不必要的医疗纠纷，同时可及时发现潜在的感染源，并进行预见性的管理，对降低医院感染率具有重要意义。%Objective:To study the blood transfusion before receptor four infectious disease index test and clinical significance. Methods:Our hospital in January 2011~December 2012 need a blood transfusion treatment of 820 cases of patients, respectively, by the blood in before treponema pallidum antibody (anti-TP), human immunodeficiency virus antibody (anti-HIV1/2), and hepatitis b surface antigen (HBSAg), hepatitis c virus antibody (anti-HCV) four infectious disease index detection, this paper discusses the above index by blood before the clinical significance of detection. Results:The anti-TP positive 9 cases, positive rate is 1.10%;Anti-HIV1/2 positive 1 example, positive rate is 0.12%;HBSAg positive 65 example, positive rate is 7.93%;Anti-HCV positive in 5 cases, positive rate is 0.61%;The male patients with positive 56 patients, positive rate is 13.59%;Female positive patients, 24 cases were positive rate is 5.97%;The male patients with infectious diseases significantly higher than female, two kinds of sex compared with significant difference, there is statistical significance (P<0.05). Conclusion:Before blood transfusion of blood donors by anti-TP, anti-HIV1/2, HBSAg, anti-HCV four infectious disease index test can determine whether patients with blood by before with the above four and blood transfusion related infectious diseases, to avoid unnecessary after blood transfusion of medical dispute, at the same time can timely find potential source of infection, and predictive management, to reduce hospital infection rate has important significance.
展开▼
